Alignment Healthcare [ALHC] vs Cigna [CI] Detailed Stock Comparison
Alignment Healthcare
NASDAQ
Loading...
Cigna
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Alignment Healthcare wins in 3 metrics, Cigna wins in 15 metrics, with 0 ties. Cigna appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Alignment Healthcare | Cigna | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -22.24 | 16.28 | Alignment Healthcare |
| Price-to-Book Ratio | 21.47 | 1.97 | Cigna |
| Debt-to-Equity Ratio | 233.85 | 76.10 | Cigna |
| PEG Ratio | 0.14 | 9.48 | Alignment Healthcare |
| EV/EBITDA | 356.76 | 9.21 | Cigna |
| Profit Margin (TTM) | -1.53% | 1.92% | Cigna |
| Operating Margin (TTM) | 2.30% | 3.67% | Cigna |
| EBITDA Margin (TTM) | 2.30% | 3.67% | Cigna |
| Return on Equity | -38.53% | 13.18% | Cigna |
| Return on Assets (TTM) | -1.50% | 3.98% | Cigna |
| Free Cash Flow (TTM) | $-6.65M | $8.96B | Cigna |
| Dividend Yield | N/A | 1.37% | N/A |
| 1-Year Return | 70.44% | -14.98% | Alignment Healthcare |
| Price-to-Sales Ratio (TTM) | 0.91 | 0.30 | Cigna |
| Enterprise Value | $2.81B | $105.08B | Cigna |
| EV/Revenue Ratio | 0.84 | 0.40 | Cigna |
| Gross Profit Margin (TTM) | 13.15% | N/A | N/A |
| Revenue per Share (TTM) | $17 | $961 | Cigna |
| Earnings per Share (Diluted) | $-0.27 | $18.23 | Cigna |
| Beta (Stock Volatility) | 1.16 | 0.48 | Cigna |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Alignment Healthcare vs Cigna Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Alignment Healthcare | 5.19% | 6.61% | 26.40% | 3.07% | 19.88% | 36.68% |
| Cigna | -1.19% | 3.65% | 2.09% | -5.09% | 0.38% | 9.64% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Alignment Healthcare | 70.44% | 7.26% | -8.72% | -8.72% | -8.72% | -8.72% |
| Cigna | -14.98% | 5.64% | 66.13% | 118.29% | 825.43% | 700.40% |
Performance & Financial Health Analysis: Alignment Healthcare vs Cigna
| Metric | ALHC | CI |
|---|---|---|
| Market Information | ||
| Market Cap | $3.03B | $79.24B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 2,856,061 | 2,081,340 |
| 90 Day Avg. Volume | 3,567,847 | 1,899,187 |
| Last Close | $15.80 | $300.95 |
| 52 Week Range | $8.24 - $21.06 | $256.89 - $370.83 |
| % from 52W High | -24.98% | -18.84% |
| All-Time High | $28.59 (May 03, 2021) | $370.83 (Sep 16, 2024) |
| % from All-Time High | -44.74% | -18.84% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.49% | 0.11% |
| Quarterly Earnings Growth | 0.49% | -0.01% |
| Financial Health | ||
| Profit Margin (TTM) | -0.02% | 0.02% |
| Operating Margin (TTM) | 0.02% | 0.04% |
| Return on Equity (TTM) | -0.39% | 0.13% |
| Debt to Equity (MRQ) | 233.85 | 76.10 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.71 | $150.84 |
| Cash per Share (MRQ) | $2.54 | $19.26 |
| Operating Cash Flow (TTM) | $63.23M | $5.29B |
| Levered Free Cash Flow (TTM) | $44.12M | $4.47B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.37% |
| Last 12-Month Dividend | N/A | $4.31 |
Valuation & Enterprise Metrics Analysis: Alignment Healthcare vs Cigna
| Metric | ALHC | CI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -22.24 | 16.28 |
| Forward P/E | -29.98 | 9.48 |
| PEG Ratio | 0.14 | 9.48 |
| Price to Sales (TTM) | 0.91 | 0.30 |
| Price to Book (MRQ) | 21.47 | 1.97 |
| Market Capitalization | ||
| Market Capitalization | $3.03B | $79.24B |
| Enterprise Value | $2.81B | $105.08B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.84 | 0.40 |
| Enterprise to EBITDA | 356.76 | 9.21 |
| Risk & Other Metrics | ||
| Beta | 1.16 | 0.48 |
| Book Value per Share (MRQ) | $0.71 | $150.84 |
Financial Statements Comparison: Alignment Healthcare vs Cigna
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ALHC | CI |
|---|---|---|
| Revenue/Sales | $926.93M | $67.23B |
| Cost of Goods Sold | $820.90M | N/A |
| Gross Profit | $106.03M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-5.39M | N/A |
| EBITDA | $2.24M | N/A |
| Pre-Tax Income | $-9.33M | $2.02B |
| Income Tax | $21,000 | $389.00M |
| Net Income (Profit) | $-9.35M | $1.63B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ALHC | CI |
|---|---|---|
| Cash & Equivalents | $446.18M | $8.33B |
| Total Current Assets | $774.49M | N/A |
| Total Current Liabilities | $457.12M | N/A |
| Long-Term Debt | $329.50M | $26.46B |
| Total Shareholders Equity | $109.00M | $40.41B |
| Retained Earnings | $-1.02B | $44.43B |
| Property, Plant & Equipment | $7.75M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ALHC | CI |
|---|---|---|
| Operating Cash Flow | $-38.58M | $-493.00M |
| Capital Expenditures | $-8.25M | $-327.00M |
| Free Cash Flow | $8.36M | $1.59B |
| Debt Repayment | N/A | $-700.00M |
| Common Stock Repurchase | N/A | $-1.51B |
Short Interest & Institutional Ownership Analysis
| Metric | ALHC | CI |
|---|---|---|
| Shares Short | 13.48M | 2.45M |
| Short Ratio | 3.55 | 1.30 |
| Short % of Float | 0.10% | 0.01% |
| Average Daily Volume (10 Day) | 2,856,061 | 2,081,340 |
| Average Daily Volume (90 Day) | 3,567,847 | 1,899,187 |
| Shares Outstanding | 191.78M | 273.79M |
| Float Shares | 145.26M | 265.64M |
| % Held by Insiders | 0.05% | 0.02% |
| % Held by Institutions | 0.97% | 0.90% |
Dividend Analysis & Yield Comparison: Alignment Healthcare vs Cigna
| Metric | ALHC | CI |
|---|---|---|
| Last 12-Month Dividend | N/A | $4.31 |
| Last 12-Month Dividend Yield | N/A | 1.37% |
| 3-Year Avg Annual Dividend | N/A | $4.35 |
| 3-Year Avg Dividend Yield | N/A | 0.42% |
| 3-Year Total Dividends | N/A | $13.04 |
| Ex-Dividend Date | N/A | Mar 05, 2025 |